Live Quote · OTCSOLTFHealthcare · Biotechnology

Nxera Pharma Co., Ltd.

$6.00▼ 5.81%($-0.37)

TickerSpark Score

53/100

▌ Mixed

64

Valuation

40

Profitability

25

Growth

76

Health

60

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SOLTF research report →

52-Week Range46% of range

Low

$4.90

Current

$6.00

High

$7.31

Company Overviewsoseiheptares.com

About the company

Nxera Pharma Co. , Ltd. is a biopharmaceutical enterprise specializing in the development and global commercialization of pharmaceutical products.

CEO: Christopher Cargill
IPO: 2013
Employees: 387
HQ: Tokyo, JP

Price Chart

-9.09% · this period

Valuation

Market Cap: $550.39M
P/E: -8.78
P/S: 2.60
P/B: 1.38
EV/EBITDA: 62.51
Div Yield: 0.00%

Profitability

Gross Margin: 77.50%
Op Margin: -6.59%
Net Margin: -29.15%
ROE: -15.58%
ROIC: -1.80%

Growth & Income

Revenue: $29.64B · 2.79%
Net Income: $-12,540,934,000 · -159.22%
EPS: $-138.80 · -157.28%
Op Income: $-8,083,047,000
FCF YoY: 66.30%

Performance & Tape

52W High: $7.31
52W Low: $4.90
50D MA: $6.59
200D MA: $5.84
Beta: 0.24
Avg Volume: 1.14K

Get TickerSpark's AI analysis on SOLTF

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · SOLTF